Pathological speech intelligibility assessment on NeuroVoz Sentence
0.86PCCASRIC
Evaluation Results
| Method | Links | |
|---|---|---|
| ASRICProtocol=MC2026.03 | 0.86 | |
| ASRICProtocol=EX2026.03 | 0.86 | |
| PER (SEM)Protocol=EX2026.03 | 0.85 | |
| PER (SEM)Protocol=MC2026.03 | 0.83 | |
| DArtPProtocol=MC2026.03 | 0.79 | |
| DArtPProtocol=EX2026.03 | 0.79 | |
| ConfidenceProtocol=EX2026.03 | 0.78 | |
| ArtPProtocol=EX2026.03 | 0.78 | |
| ArtPProtocol=MC2026.03 | 0.77 | |
| ConfidenceProtocol=MC2026.03 | 0.76 | |
| NADProtocol=EX2026.03 | 0.75 | |
| PER (Phone)Protocol=EX2026.03 | 0.72 | |
| PER (Phone)Protocol=MC2026.03 | 0.7 | |
| NADProtocol=MC2026.03 | 0.7 | |
| P-ESTOIProtocol=EX2026.03 | 0.53 | |
| P-ESTOIProtocol=MC2026.03 | 0.4 | |
| Speech RateProtocol=EX2026.03 | 0.32 | |
| Speech RateProtocol=MC2026.03 | 0.26 | |
| CPPProtocol=EX2026.03 | 0.19 | |
| CPPProtocol=MC2026.03 | 0.17 | |
| VSAProtocol=EX2026.03 | 0.05 | |
| VSAProtocol=MC2026.03 | 0.01 | |
| sigma_f0Protocol=MC2026.03 | -0.3 | |
| sigma_f0Protocol=EX2026.03 | -0.31 |